Trajectories of change in depression severity during treatment with antidepressants (Q43253362)

17 November 2017

Trajectories of change in depression severity during treatment with antidepressants (English)

1 reference

17 November 2017

4

1 reference

17 November 2017

Katherine J. Aitchison

11

1 reference

17 November 2017

R Uher

1

0 references

Marcella Rietschel

10

object named as

M Rietschel

1 reference

17 November 2017

B Muthén

2

1 reference

17 November 2017

D Souery

3

1 reference

17 November 2017

J Jaracz

5

1 reference

17 November 2017

A Placentino

6

1 reference

17 November 2017

A Petrovic

7

1 reference

17 November 2017

A Zobel

8

1 reference

17 November 2017

N Henigsberg

9

1 reference

17 November 2017

A Farmer

12

1 reference

17 November 2017

P McGuffin

13

1 reference

17 November 2017

language of work or name

English

0 references

publication date

29 October 2009

1 reference

17 November 2017

Psychological Medicine

1 reference

17 November 2017

40

1 reference

17 November 2017

8

1 reference

17 November 2017

1367-1377

1 reference

Development of a Rating Scale for Primary Depressive Illness

17 November 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

A Coefficient of Agreement for Nominal Scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

Observational research, randomised trials, and two views of medical science

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

A latent-class mixture model for incomplete longitudinal Gaussian data

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

Genetic predictors of response to antidepressants in the GENDEP project

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

Measuring depression: comparison and integration of three scales in the GENDEP study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

The implications of gene-environment interactions in depression: will cause inform cure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

Application of pharmacogenetics to psychotic disorders: the first consensus conference. The Consensus Group for Outcome Measures in Psychoses for Pharmacological Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

The definition and operational criteria for treatment outcome of major depressive disorder. A review of the current research literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder. A replication of findings with the use of a double-blind, placebo-controlled trial of Hypericum perforatum versus fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

Relationships among measures of treatment outcome in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

Accounting for dropout bias using mixed-effects models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

Methodological issues in current antipsychotic drug trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

7 January 2021

Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

7 January 2021

Breaking up is hard to do: the heartbreak of dichotomizing continuous data.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

7 January 2021

What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

7 January 2021

Is there a common resilience mechanism underlying antidepressant drug response? Evidence from 2848 patients.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

7 January 2021

Dichotomizing continuous predictors in multiple regression: a bad idea

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

7 January 2021

Identification of true drug response to antidepressants. Use of pattern analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

7 January 2021

Antidepressants on trial: how valid is the evidence?

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

7 January 2021

The arbitrariness of response definition in clinical trials with antidepressants

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991528

7 January 2021

10.1017/S0033291709991528

Identifiers

DOI

1 reference

17 November 2017

1 reference